Jacobi Capital Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Jacobi Capital Management’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-200	Closed	-$15K	–	1082
2021 Q3	$15K	Hold	200	–	–	﹤0.01%	963
2021 Q2	$15K	Hold	200	–	–	﹤0.01%	920
2021 Q1	$14K	Hold	200	–	–	﹤0.01%	884
2020 Q4	$13K	Hold	200	–	–	﹤0.01%	817
2020 Q3	$12K	Hold	200	–	–	﹤0.01%	779
2020 Q2	$12K	Hold	200	–	–	﹤0.01%	749
2020 Q1	$11K	Hold	200	–	–	﹤0.01%	702
2019 Q4	$13K	Hold	200	–	–	﹤0.01%	708
2019 Q3	$11K	Hold	200	–	–	﹤0.01%	721
2019 Q2	$12K	Hold	200	–	–	﹤0.01%	706
2019 Q1	$12K	Hold	200	–	–	﹤0.01%	674
2018 Q4	$11K	Hold	200	–	–	﹤0.01%	648
2018 Q3	$13K	Sell	200 -244	-55%	-$15.2K	﹤0.01%	668
2018 Q2	$26K	Buy	444 +1	+0.2%	+$58	0.01%	531
2018 Q1	$24K	Hold	443	–	–	0.01%	528
2017 Q4	$27K	Buy	443 +400	+930%	+$22.9K	0.01%	485
2017 Q3	$3K	Hold	43	–	–	﹤0.01%	810
2017 Q2	$2K	Buy	+43	New	+$2.43K	﹤0.01%	765

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CCP

Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

TPWM

Twelve Points Wealth Management Concord, Massachusetts $455M AUM 19.98% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

LJAC

L.J. Altfest & Co New York $935M AUM 27.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return

Jacobi Capital Management's PPH Position: Q4 2021 in Review

Jacobi Capital Management sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2021, closing a stake of 200 shares — an estimated $15K sold.

Jacobi Capital Management first reported a position in PPH in Q2 2017 and held it in 18 quarters. The position peaked at $27K in Q4 2017. 63 funds tracked by Wall St. Rank hold PPH as of Q4 2021.

Jacobi Capital Management reported no remaining VanEck Pharmaceutical ETF position as of Q4 2021 after selling out during the quarter.
Jacobi Capital Management sold 200 VanEck Pharmaceutical ETF shares in Q4 2021, an estimated $15K.
Jacobi Capital Management first reported a position in VanEck Pharmaceutical ETF in Q2 2017 and held it in 18 quarters.
Jacobi Capital Management's VanEck Pharmaceutical ETF position peaked at $27K in Q4 2017.
63 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2021.

Based on Jacobi Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.